Pregnancy and Epilepsy
- 1 December 1991
- Vol. 32 (s6) , S51-S59
- https://doi.org/10.1111/j.1528-1157.1991.tb05893.x
Abstract
Women with epilepsy account for approximately 0.5% of all pregnancies. Their pregnancies are high risk because of an increased frequency of maternal seizures, complications of pregnancy, and adverse pregnancy outcomes. The increase in seizure frequency is associated with a progressive decline in antiepileptic drug (AED) levels during pregnancy even with constant dosing. Fetal deaths after a generalized seizure, although rare, have been reported, and a marked decline in fetal heart rate has been demonstrated after such seizures during delivery. AEDs have been implicated in causing a twofold increase in the rate of congenital malformations, a variety of minor physical anomalies, mostly involving the midface, and a neonatal hemorrhagic disorder. The clinician caring for a pregnant woman with epilepsy is therefore faced with a dilemma and must carefully chart a middle ground providing effective seizure control while minimizing fetal exposure to AEDs.Keywords
This publication has 55 references indexed in Scilit:
- Pattern of Malformations in the Children of Women Treated with Carbamazepine during PregnancyNew England Journal of Medicine, 1989
- Carbamazepine Protein Binding and Disposition in PregnancyTherapeutic Drug Monitoring, 1985
- Congenital MalformationsNew England Journal of Medicine, 1983
- Anticonvulsants during Pregnancy and LactationClinical Pharmacokinetics, 1982
- Plasma Protein Binding of Drugs in PregnancyClinical Pharmacokinetics, 1982
- Antiepileptic DrugsClinical Pharmacokinetics, 1979
- Plasma Drug Level Monitoring in PregnancyClinical Pharmacokinetics, 1977
- Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndromeThe Journal of Pediatrics, 1976
- The fetal hydantoin syndromeThe Journal of Pediatrics, 1975
- The fetal trimethadione syndromeThe Journal of Pediatrics, 1975